T1 Condition 374 398 neurofibromatosis type 1
T2 Gene 519 530 Selumetinib
T3 Condition 374 386 neurofibroma
T4 Condition 1852 1864 neurofibroma
T5 Intervention 494 500 plasma
T6 Condition 1100 1105 tumor
T7 Biomarker 1514 1529 creatine kinase
T8 Protein 2252 2265 dose-adjusted
T9 Gene_or_gene_product 344 352  1 and 2
T10 Biomarker 690 701 selumetinib
T11 Biomarker 282 293 ARRY-142886
T13 Condition 758 770 neurofibroma
T14 Condition 1917 1922 tumor
T15 Disease 1455 1469 acneiform rash
T16 Protein 165 202 RAS–mitogen-activated protein kinase 
T17 Condition 2163 2175 neurofibroma
T18 Biomarker 258 269 selumetinib
T19 Condition 114 126 neurofibroma
T20 Organism 1609 1617 children
T21 Biomarker 1153 1164 selumetinib
T22 Protein 1404 1409 toxic
T23 Disease 2028 2046 tumor-related pain
T24 Protein 271 278 AZD6244
T25 Condition 414 437 plexiform neurofibromas
T26 Condition 998 1010 neurofibroma
T27 Intervention 1471 1487 gastrointestinal
T28 Condition 71 127 neurofibromatosis type 1–related plexiform neurofibromas
T29 Biomarker 2281 2292 selumetinib
T30 Condition 725 749 neurofibromatosis type 1
T31 Condition 725 770 neurofibromatosis type 1–related neurofibroma
T32 Organism 1032 1040 children
T33 Biomarker 1434 1445 selumetinib
T34 Condition 2213 2225 neurofibroma
T36 Species 1884 1888 mice
T37 Biomarker 1691 1702 selumetinib
T38 Condition 856 879 plexiform neurofibromas
T39 Organism 1166 1174 Patients
T40 Biomarker 1196 1207 selumetinib
T41 Condition 1744 1749 tumor
T42 Protein 326 331  MAPK
T43 Gene_or_gene_product 1784 1787 ≥20
T44 Organism 357 365 children
T45 Condition 2028 2033 tumor
T46 Condition 424 436 neurofibroma
T47 Organism 2149 2157 children
T48 Condition 2163 2187 neurofibromatosis type 1
T49 Condition 866 878 neurofibroma
T50 Organism 1806 1814 children
T51 Protein 2315 2320 toxic
T52 Gene_or_gene_product 1956 1959 ≥20
T53 Species 710 715 mouse
T54 Condition 725 737 neurofibroma
T55 Gene_or_gene_product 299 339 oral selective inhibitor of MAPK kinase 
T56 Condition 71 83 neurofibroma
T57 Condition 71 95 neurofibromatosis type 1
T58 Biomarker 1587 1598 selumetinib
